# A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa

> clinical trial · VERIFIED · 2026-07-28

Status: RECRUITING · Sponsor: Revagenix, Inc. · Condition: Healthy Participants

- Company: Revagenix, Inc.
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07709494

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.